About 4D Molecular Therapeutics, Inc. 
4D Molecular Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 47 Schemes (25.48%)
Foreign Institutions
Held by 98 Foreign Institutions (20.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-55 Million
Pharmaceuticals & Biotechnology
USD 326 Million ()
NA (Loss Making)
NA
0.00%
-0.68
-46.61%
0.77






